Category: BOD

Tehila Ben Moshe Ph.D., Co-Founder, Chairperson & Chief Executive Officer

Tehila is the Co-Founder of Biond. She has served as Biond’s CEO and Board of Directors chairperson since the company’s inception. Tehila brings over a decade of scientific excellence and entrepreneurial leadership in biotech and pharma, combined with proven leadership skills and business acumen. Prior to founding Biond, Tehila was the CEO of cCAM Biotherapeutics […]

Read More

Ronit Bendori Ph.D.

Ronit is a general partner at Evergreen, focuses on investments in the healthcare sector. Since 2014 she is also an early stage private investor. Before joining Evergreen, Ronit served as Vice President of Pharmos Ltd. (NASDAQ: PARS). Prior to that Ronit held senior positions at InterPharm Ltd. (Israel) and Ares-Serono (Switzerland). Ronit is a member […]

Read More

David Sidransky M.D.

Dr. Sidransky has served as a member of our Board of Directors since 2017. He is a renowned oncologist and research scientist named and profiled by TIME magazine in 2001 as one of the top physicians and scientists in America, recognized for his work with early detection of cancer. Since 1994, Dr. Sidransky is the […]

Read More

Guy Harmelin M.D.

Guy has served as a member of our Board of Directors since 2018. Guy is an entrepreneur and investor and has invested and worked with multiple successful companies including Lemonade (LMND:NYSE), Innoviz (INVZ:NASDAQ), American Well (AMWL:NYSE), Ecoppia (ECPA:TLV, Ayala Pharma (AYLA:NASDAQ), Quantum Machines, Tabit, Assured Allies and Oxford Nanopore. Guy was the Co-Founder and CEO […]

Read More

Jerome B. Zeldis M.D., Ph.D.

Dr. Zeldis was appointed to our Board of Directors in June 2020. He is Executive Chair of ViralClear Pharmaceuticals, Inc. and previously served as Chief Medical Officer and President of Clinical Research, Medical Affairs, Drug Safety, Quality, and Regulatory at Sorrento Therapeutics, Inc. Prior to Sorrento he had a nearly 20-year career at Celgene during […]

Read More